What is YUTIQ? YUTIQ® (fluocinolone acetonide intravitreal implant) 0.18 mg

Uveitis treatment built for the long term

If you and your eye doctor have identified posterior segment uveitis symptoms and decided to move forward with YUTIQ^® (fluocinolone acetonide intravitreal implant) 0.18 mg, innovative treatment awaits with lasting results for up to 36 months. YUTIQ is a proven single-injection treatment for chronic non-infectious uveitis affecting the back of the eye (posterior segment uveitis).

There’s a lot to see in 3 years, and YUTIQ works to help keep uveitis from
interrupting your life.

What is YUTIQ?

YUTIQ is a tiny implant that is placed in the eye, designed to deliver a sustained release of medicine for up to 36 months. Treating within the eye, YUTIQ delivers a low, continuous dose of medicine.

In scientific studies, patients with YUTIQ had up to a 60% decrease in uveitis recurrence at 6 months. There were similar results at 12 months, where patients with YUTIQ had up to a 58% decrease in uveitis recurrence.

YUTIQ was studied in 2 different trials in patients with non-infectious uveitis in the back of the eye. In the first study, 87 patients were treated with YUTIQ and 42 were treated with a sham injection (the control group). In the second study, 101 patients were treated with YUTIQ and 52 with a sham injection. The main goal of these studies was to determine how many patients experienced a repeat episode of uveitis within 6 months of treatment with either YUTIQ or the sham injection.

Most patients treated with YUTIQ did not experience a repeat uveitis episode; at 36 months, around 94% of patients did not experience uveitis, compared to 71% of sham injection patients. YUTIQ is designed for longer duration so you may have fewer injection appointments. Some of the common side effects in more than 10% of patients treated with YUTIQ are cataracts, reduced visual acuity (unclear vision), and macular edema (swelling around the retina).

The idea that I wouldn’t have to submit my eyeballs, or my psyche, to the trauma of receiving injections every 8 weeks was my main motivation for agreeing to YUTIQ treatment.

– Christine, a YUTIQ patient

Talk with your retina or uveitis specialist about treatment with YUTIQ. Don’t have a retina specialist? Find one here.

*People pictured are not real patients unless otherwise noted.

INDICATION AND USAGE

YUTIQ^® (fluocinolone acetonide intravitreal implant) 0.18 mg contains a corticosteroid and is for the treatment of patients with chronic, non-infectious uveitis affecting the back of the eye.

IMPORTANT SAFETY INFORMATION

Do not take YUTIQ if:

You have, or suspect you have, an eye infection
If you have been told you are allergic to any of the ingredients in YUTIQ

YUTIQ may cause serious side effects, including:

Injection-related effects, steroid-related effects and movement of the implant.

Call your doctor if your eye becomes red, sensitive to light, painful or if your vision changes or becomes blurred.

You may experience temporary blurred vision. Do not drive or use machines until your vision clears.

The most common side effects in the eye were cataract and reduced clarity of vision. The most common side effects not related to the eye were upper respiratory infection, high blood pressure and joint pain.

If you are pregnant, become pregnant or consider breastfeeding after having received YUTIQ inform your doctor immediately.

Please see full Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800‑FDA‑1088.

YUTIQ, the YUTIQ logo, and the EyePoint logo are registered trademarks of EyePoint Pharmaceuticals, Inc. EyePoint Assist is a service mark of EyePoint Pharmaceuticals, Inc.

480 Pleasant Street, Suite B300, Watertown, MA 02472

12/2022

US-YUT-2200116

INDICATION AND USAGE

YUTIQ^® (fluocinolone acetonide intravitreal implant) 0.18 mg contains a corticosteroid and is for the treatment of patients with chronic, non-infectious uveitis affecting the back of the eye.

IMPORTANT SAFETY INFORMATION

Do not take YUTIQ if:

You have, or suspect you have, an eye infection
If you have been told you are allergic to any of the ingredients in YUTIQ

Are you an eye care professional in the US?

By following this link, you will visit a site maintained by a third party who is responsible for its content. This link is not owned or operated by EyePoint Pharmaceuticals, Inc.